Author

Robbert Boudewijns

Rega Institute for Medical ResearchORCID 0000-0002-5984-7279Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Organism:rat· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:non-human primate· 1 Assay:proteomics· 1

Frequent Co-Authors

Birgit WeynandiD· 2 shared Hendrik Jan ThibautiD· 2 shared Laura SeldeslachtsiD· 2 shared Laurens LiesenborghsiD· 2 shared Sebastiaan ter HorstiD· 2 shared Xin ZhangiD· 2 shared Alison V. TurneriD· 1 shared Alistair J. HenryiD· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Birgit WeynandORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologybioRxivPreprintMar 8, 2021

Drug development of an affinity enhanced, broadly neutralizing heavy chain-only antibody that restricts SARS-CoV-2 in rodents

Bert Schepens, Loes van Schie, Wim Nerinckx…·Xavier Saelens

The paper describes the development of a broadly neutralizing antibody, XVR011, effective against SARS-CoV-2 and its variants in animal models.

7 citations

𝕏 PostBluesky

MicrobiologybioRxivPreprintJul 8, 2020

A single-dose live-attenuated YF17D-vectored SARS-CoV2 vaccine candidate

Lorena Sanchez Felipe, Thomas Vercruysse, Sapna Sharma…·Kai D

This paper develops a single-dose YF17D-vectored SARS-CoV-2 vaccine candidate that induces neutralizing antibodies and protects against infection in hamsters.

DOI 10.1101/2020.07.08.193045

𝕏 PostBluesky